Pharmaceutical Logistics Market Size 2025-2029
The pharmaceutical logistics market size is forecast to increase by USD 44.4 billion, at a CAGR of 8.0% between 2024 and 2029.
The global pharmaceutical logistics market is defined by the growing prevalence of biologics and other temperature-sensitive drugs. This shift necessitates advanced cold chain logistics for pharmaceuticals industry to maintain product integrity. Innovations in pharmaceutical warehousing and active and intelligent packaging in pharmaceutical are critical to support these complex supply chains. The market is increasingly adopting sophisticated real-time shipment monitoring and validated shipping lanes to ensure compliance and safety. This evolution toward high-value product handling requires significant investment in both infrastructure and technology to manage the specific needs of specialty pharmaceuticals and ensure unbroken temperature control from production to patient administration, underpinning the sector's current trajectory.A primary trend shaping the market is the move toward hyper-specialization, particularly in cryogenic shipping solutions for cell and gene therapies. This requires a complete ecosystem of specialized infrastructure and expertise. However, this specialization occurs within a challenging context of a fragmented global regulatory landscape, which creates significant operational hurdles for logistics providers. Navigating disparate Good Distribution Practices (GDP) guidelines across multiple countries demands deep regional expertise and robust compliance management systems. This combination of therapeutic advancement and regulatory complexity defines the competitive environment, pushing providers to enhance their capabilities in both high-tech logistics and international compliance to succeed in this demanding sector.
What will be the Size of the Pharmaceutical Logistics Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The global pharmaceutical logistics market is characterized by a continuous evolution in service models, driven by the need to support increasingly complex therapeutic modalities. The management of biologics supply chains and cell and gene therapy logistics demands a high degree of specialization, moving beyond traditional transport to encompass integrated GxP compliant logistics. This includes the deployment of advanced solutions for real-time shipment monitoring and temperature data monitoring to ensure in-transit product integrity. Providers are focusing on building resilient and transparent networks that can adapt to the rigorous demands of new drug delivery systems and ensure the secure handling of high-value products.Regulatory mandates are a significant factor shaping operational strategies, particularly in the context of the pharmaceutical traceability market. The implementation of DSCSA compliance solutions and FMD verification systems is accelerating the adoption of digital technologies for unit-level traceability and chain of custody verification. This digital transformation is not only for compliance but also for operational efficiency, with AI-powered route optimization and predictive supply chain analytics becoming key differentiators. The integration of these systems into pharmaceutical warehousing and distribution networks is critical for enhancing security and efficiency in the delivery of specialty pharmaceuticals.
How is this Pharmaceutical Logistics Industry segmented?
The pharmaceutical logistics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Type
- Application
- Mode of transportation
- Geography
- APAC
- China
- India
- Japan
- Australia
- South Korea
- Indonesia
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Middle East and Africa
- South America
- Rest of World (ROW)
By Type Insights
The non cold chain segment is estimated to witness significant growth during the forecast period.
The non-cold chain segment, also known as controlled room temperature (CRT) logistics, is a foundational component of the pharmaceutical supply chain. It addresses the handling of products stable at ambient temperatures, such as tablets and capsules. While not requiring refrigeration, these products demand a robust framework of quality control to prevent damage from temperature excursions and humidity. Logistics providers focus on efficiency and cost optimization, utilizing GDP-compliant warehouses and passive data loggers to ensure in-transit product integrity and compliance.
This segment's market dynamics are driven by the high volume of generic and established branded medicines that constitute the majority of global healthcare products. It accounts for a significant portion of the market, with key economic regions contributing heavily to its scale; for instance, the US market alone represents approximately 21.8% of the total global demand. The ongoing push for serialization and enhanced traceability to combat counterfeiting continues to spur the adoption of digital platforms for ambient logistics services, ensuring security and visibility even for non-refrigerated goods.
Request Free Sample
The Non cold chain segment was valued at USD 66.4 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
APAC is estimated to contribute 42.6% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
The APAC pharmaceutical logistics market is the fastest-growing globally, driven by rising healthcare expenditures, government initiatives to improve healthcare access, and the region's expanding role as a global hub for pharmaceutical manufacturing and clinical research. The landscape is exceptionally diverse, ranging from the sophisticated logistics ecosystems in Japan and Singapore to the rapidly developing markets of Southeast Asia. China and India are central to this growth, generating immense outbound logistics volumes from their roles as major producers of APIs and generics, respectively.
This region is projected to contribute approximately 42.6% of the market's incremental growth, highlighting its significant opportunity. A key focus of investment across APAC is the development of cold storage infrastructure and cold chain packaging qualification to support the distribution of vaccines and sensitive biologics to vast and often remote populations. While regulatory fragmentation presents a challenge, many countries are working to harmonize standards, facilitating trade and improving product quality across this dynamic and strategically important market.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global pharmaceutical logistics market is rapidly evolving, driven by the need for robust supply chain solutions for specialty pharmaceuticals and the complex requirements of logistics for cell and gene therapies. Providers are focusing on integrated logistics for pharmaceutical manufacturing to ensure efficiency from production to delivery. A critical component is establishing strong risk management in pharmaceutical supply chains, which includes the secure transportation of controlled substances and adherence to strict GDP-compliant warehouse and distribution practices. Ensuring regulatory compliance in cross-border pharma logistics is paramount, and technologies like blockchain technology for pharmaceutical traceability are being adopted to achieve unit-level traceability for DSCSA compliance, creating a transparent and secure ecosystem. This comprehensive approach is essential for delivering effective end-to-end cold chain management services.Executing these complex strategies requires advanced operational capabilities. The use of active temperature-controlled air freight containers and validated passive packaging for international shipping is standard for maintaining product integrity across multi-modal transport for global pharma distribution. For highly sensitive products, cryogenic logistics for biological materials is essential. The industry is also seeing a rise in direct-to-patient logistics for clinical trials, which demands flawless last-mile delivery of temperature-sensitive drugs. To achieve this, companies rely on real-time temperature and humidity monitoring and leverage AI-based predictive analytics for shipment delays to proactively manage disruptions. Furthermore, there's a growing emphasis on sustainability through sustainable packaging solutions for cold chain and efficient handling of reverse logistics for pharmaceutical product returns.
What are the key market drivers leading to the rise in the adoption of Pharmaceutical Logistics Industry?
- The ascendancy of biologics and temperature-sensitive pharmaceuticals is a primary catalyst for growth in the global pharmaceutical logistics market.
A primary driver for the market is the paradigm shift toward large-molecule biologics and specialty pharmaceuticals. Unlike traditional drugs, these products are highly sensitive to temperature fluctuations, mandating a sophisticated, unbroken cold chain to ensure therapeutic efficacy. The financial and clinical stakes are immense, as even minor deviations can compromise multimillion-dollar shipments. This inherent fragility necessitates a comprehensive ecosystem of specialized infrastructure, including GDP-compliant warehousing and advanced real-time shipment monitoring. The growing pipeline of these advanced therapies directly translates into escalating demand for high-value cold chain logistics services, compelling providers to invest heavily in specialized capabilities. Approximately 42.6% of the market's incremental growth is concentrated in regions rapidly expanding their biologics manufacturing capabilities.The increasingly globalized nature of the pharmaceutical industry is another powerful market driver. Companies now operate in a highly fragmented model, sourcing active pharmaceutical ingredients (APIS), manufacturing, and distributing across different continents to optimize costs and mitigate risks. This deconstruction of the value chain creates a complex web of supply routes requiring expert logistical management, including multi-modal freight solutions and customs brokerage for pharma. Furthermore, the expansion of clinical trials into new geographic regions to access diverse patient populations fuels demand for specialized clinical trial logistics. Managing time- and temperature-sensitive investigational products and biological samples across multiple countries with varying regulations creates a significant and growing need for logistics partners with a global network and deep regulatory expertise.
What are the market trends shaping the Pharmaceutical Logistics Industry?
- A key upcoming trend in the market is the hyper-specialization in cryogenic and ultra-low temperature logistics to support advanced therapies.
The market is experiencing a profound shift toward hyper-specialization, particularly in cryogenic and ultra-low temperature (ULT) logistics. This trend is a direct result of the rise of cell and gene therapies (CGTS), which are living biological materials requiring temperatures below minus 150 degrees Celsius to maintain viability. This fundamentally redefines logistical complexity, moving beyond standard cold chain logistics for pharmaceuticals industry to require a complete ecosystem of cryogenic shipping solutions, specialized handling protocols, and advanced real-time monitoring. Logistics providers are becoming integral partners in the therapeutic value chain, responsible for maintaining the chain of custody for these irreplaceable, patient-specific treatments. This evolution represents a strategic pivot toward high-value, patient-centric new drug delivery systems where precision is paramount.A second major trend is the rapid adoption of AI-powered predictive analytics and integrated digital control towers. This move toward digitalization aims to create end-to-end supply chain visibility and transition operations from reactive to proactive. These platforms ingest real-time data from IoT sensors, weather APIs, and traffic data to predict potential disruptions, such as temperature excursions or shipping delays. This predictive capability is crucial for building supply chain resilience and ensuring patient safety, particularly for specialty pharmaceuticals. With nearly 26.05% of the market opportunity originating from technologically advanced regions, these digital systems are also instrumental in ensuring compliance with regulations mandating unit-level traceability, reinforcing the link between technology adoption and market leadership.
What challenges does the Pharmaceutical Logistics Industry face during its growth?
- A significant challenge affecting industry growth is the stringent and fragmented nature of the global regulatory landscape for pharmaceutical transportation.
A formidable challenge is the complex and fragmented international regulatory landscape. Logistics providers must navigate a labyrinth of disparate Good Distribution Practices (GDP) and customs regulations that vary significantly between countries. This regulatory patchwork affects every aspect of the supply chain, from documentation to packaging and serialization mandates, creating an immense operational burden. Compliance is non-negotiable, with failures leading to shipment delays, financial penalties, and risks to patient safety. The need to invest in dedicated compliance teams and sophisticated IT systems is constant, especially as a single shipment may transit multiple jurisdictions. This complexity is a significant operational hurdle, particularly with the lack of global harmonization in areas like traceability mandates, where over 21.07% of shipments are destined for highly regulated, yet diverse, economic blocs.Maintaining cold chain integrity while managing rising cost pressures presents another persistent challenge. The execution of unbroken, temperature-controlled logistics is an operationally intensive and expensive undertaking. It requires substantial capital investment in infrastructure like temperature-controlled warehouses, refrigerated vehicles, and specialized thermal packaging. The risk of a temperature excursion can result in the loss of millions of dollars in product and deprive a patient of a life-saving treatment. Compounding this operational difficulty is the intense pressure from pharmaceutical manufacturers to reduce logistics costs. This forces providers into a difficult balancing act: investing in premium, state-of-the-art cold chain solutions to guarantee product integrity while remaining price-competitive in a budget-constrained healthcare environment.
Exclusive Customer Landscape
The pharmaceutical logistics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the pharmaceutical logistics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, pharmaceutical logistics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
AP Moller Maersk AS - Key services are centered on delivering global, temperature-controlled freight forwarding and integrated hub management solutions designed specifically for pharmaceutical products. The focus is on ensuring end-to-end product integrity through specialized handling and strict adherence to regulatory standards across the supply chain. This includes managing complex international shipments and providing the necessary infrastructure to support the unique requirements of the healthcare industry.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- AP Moller Maersk AS
- AWL India Pvt. Ltd.
- Bollore Logistics
- CEVA Logistics SA
- CJ CheilJedang Corp.
- CMA CGM Group
- DACHSER SE
- DHL International GmbH
- DSV AS
- FedEx Corp.
- Gemadept Corp.
- GEODIS
- Kuehne Nagel Management AG
- Rhenus SE and Co. KG
- Schenker AG
- SF Express Co. Ltd.
- Tiong Nam Logistics Holdings Berhad
- United Parcel Service Inc.
- YCH Group
- YUSEN LOGISTICS CO. LTD.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Pharmaceutical Logistics Market
In June 2024, United Parcel Service Inc. opened a new 10,000-square-meter healthcare logistics facility in Rome, Italy, enhancing its cold chain capabilities with storage for products at temperatures ranging from 2C to 8C and down to -80C.In May 2024, CEVA Logistics, a subsidiary of CMA CGM Group, opened a new 20,000-square-meter temperature-controlled healthcare and pharmaceutical warehouse in Johannesburg, South Africa, to serve the Southern African market.In April 2024, World Courier, a part of Cencora, announced a major expansion of its direct-to-patient services in Japan, investing in its network of qualified couriers and technology platforms to manage patient scheduling and consent for home-based clinical trials and treatments.In April 2024, a consortium of leading US pharmaceutical companies and distributors, including Cencora and Cardinal Health, announced the successful completion of a large-scale interoperability pilot, demonstrating the industry's readiness for the Drug Supply Chain Security Act's (DSCSA) final requirements for electronic, unit-level traceability.
Research Analyst Overview
The global pharmaceutical logistics market is defined by its stringent adherence to maintaining cold chain integrity through sophisticated temperature-controlled logistics. The sector anticipates an expansion of approximately 8% in operational capacity to support these complex needs. Operations pivot on good distribution practices (GDP) and the use of GDP-compliant warehousing for storing products at controlled room temperature (CRT). The selection between active thermal packaging and passive packaging systems, including insulated shipping containers and refrigerated container transport, is critical. Effective temperature excursion management across validated shipping lanes is fundamental for successful biopharmaceutical transport. This meticulous approach to specialty drug handling ensures product efficacy and safety from origin to destination, integrating robust supply chain security protocols throughout the transit process.Achieving end-to-end supply chain visibility increasingly relies on integrating advanced technologies. The implementation of pharmaceutical serialization enables unit-level traceability, which is reinforced by blockchain in pharma supply chain for enhanced chain of custody verification. Supply chain visibility platforms aggregate data from real-time shipment monitoring systems, which utilize IoT-enabled data loggers and geofencing and GPS tracking. This data-rich environment facilitates predictive supply chain analytics and AI-powered route optimization. The evolution of service models includes direct-to-patient distribution and specialized cell and gene therapy logistics. Managing the complexities of clinical trial logistics, pharmaceutical reverse logistics, customs brokerage for pharma, and multi-modal freight solutions necessitates constant regulatory compliance management and proactive supply chain risk mitigation. The deployment of cryogenic shipping solutions supports ultra-sensitive biologics, completing the spectrum of services for last-mile pharmaceutical delivery.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Pharmaceutical Logistics Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
293
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 8.0%
|
|
Market growth 2024-2029
|
USD 44.4 billion
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
7.9%
|
|
Key countries
|
China, India, Japan, Australia, South Korea, Indonesia, US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, Saudi Arabia, UAE, South Africa, Israel, Turkey, Brazil, Argentina, Colombia
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Pharmaceutical Logistics Market Research and Growth Report?
- CAGR of the Pharmaceutical Logistics industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across APAC, North America, Europe, Middle East and Africa, South America
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the pharmaceutical logistics market growth of industry companies
We can help! Our analysts can customize this pharmaceutical logistics market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Mode of Transportation
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Pharmaceutical Logistics Market 2019 - 2023
- Historic Market Size - Data Table on Global Pharmaceutical Logistics Market 2019 - 2023 ($ billion)
- 5.2 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
- 5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ billion)
- 5.4 Mode of Transportation segment analysis 2019 - 2023
- Historic Market Size - Mode of Transportation Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 The AI impact on Global Pharmaceutical Logistics Market
7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
- 8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 Non cold chain - Market size and forecast 2024-2029
- Chart on Non cold chain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Non cold chain - Market size and forecast 2024-2029 ($ billion)
- Chart on Non cold chain - Year-over-year growth 2024-2029 (%)
- Data Table on Non cold chain - Year-over-year growth 2024-2029 (%)
- 8.4 Cold chain - Market size and forecast 2024-2029
- Chart on Cold chain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Cold chain - Market size and forecast 2024-2029 ($ billion)
- Chart on Cold chain - Year-over-year growth 2024-2029 (%)
- Data Table on Cold chain - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)
9 Market Segmentation by Application
- 9 Market Segmentation by Application
- 9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 9.3 Storage - Market size and forecast 2024-2029
- Chart on Storage - Market size and forecast 2024-2029 ($ billion)
- Data Table on Storage - Market size and forecast 2024-2029 ($ billion)
- Chart on Storage - Year-over-year growth 2024-2029 (%)
- Data Table on Storage - Year-over-year growth 2024-2029 (%)
- 9.4 Transportation - Market size and forecast 2024-2029
- Chart on Transportation - Market size and forecast 2024-2029 ($ billion)
- Data Table on Transportation - Market size and forecast 2024-2029 ($ billion)
- Chart on Transportation - Year-over-year growth 2024-2029 (%)
- Data Table on Transportation - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)
10 Market Segmentation by Mode of Transportation
- 10 Market Segmentation by Mode of Transportation
- 10.1 Market segments
- Chart on Mode of Transportation - Market share 2024-2029 (%)
- Data Table on Mode of Transportation - Market share 2024-2029 (%)
- 10.2 Comparison by Mode of Transportation
- Chart on Comparison by Mode of Transportation
- Data Table on Comparison by Mode of Transportation
- 10.3 Road - Market size and forecast 2024-2029
- Chart on Road - Market size and forecast 2024-2029 ($ billion)
- Data Table on Road - Market size and forecast 2024-2029 ($ billion)
- Chart on Road - Year-over-year growth 2024-2029 (%)
- Data Table on Road - Year-over-year growth 2024-2029 (%)
- 10.4 Sea - Market size and forecast 2024-2029
- Chart on Sea - Market size and forecast 2024-2029 ($ billion)
- Data Table on Sea - Market size and forecast 2024-2029 ($ billion)
- Chart on Sea - Year-over-year growth 2024-2029 (%)
- Data Table on Sea - Year-over-year growth 2024-2029 (%)
- 10.5 Air - Market size and forecast 2024-2029
- Chart on Air - Market size and forecast 2024-2029 ($ billion)
- Data Table on Air - Market size and forecast 2024-2029 ($ billion)
- Chart on Air - Year-over-year growth 2024-2029 (%)
- Data Table on Air - Year-over-year growth 2024-2029 (%)
- 10.6 Rail - Market size and forecast 2024-2029
- Chart on Rail - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rail - Market size and forecast 2024-2029 ($ billion)
- Chart on Rail - Year-over-year growth 2024-2029 (%)
- Data Table on Rail - Year-over-year growth 2024-2029 (%)
- 10.7 Market opportunity by Mode of Transportation
- Market opportunity by Mode of Transportation ($ billion)
- Data Table on Market opportunity by Mode of Transportation ($ billion)
11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 APAC - Market size and forecast 2024-2029
- Chart on APAC - Market size and forecast 2024-2029 ($ billion)
- Data Table on APAC - Market size and forecast 2024-2029 ($ billion)
- Chart on APAC - Year-over-year growth 2024-2029 (%)
- Data Table on APAC - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - APAC
- Data Table on Regional Comparison - APAC
- 12.3.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.3.2 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.3.3 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.3.4 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 12.3.5 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.3.6 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 12.4 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.4.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.4.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.4.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.5 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.5.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.5.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.5.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.5.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.5.5 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 12.5.6 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 12.6 Middle East and Africa - Market size and forecast 2024-2029
- Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Middle East and Africa
- Data Table on Regional Comparison - Middle East and Africa
- 12.6.1 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 12.6.2 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.6.3 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 12.6.4 Israel - Market size and forecast 2024-2029
- Chart on Israel - Market size and forecast 2024-2029 ($ billion)
- Data Table on Israel - Market size and forecast 2024-2029 ($ billion)
- Chart on Israel - Year-over-year growth 2024-2029 (%)
- Data Table on Israel - Year-over-year growth 2024-2029 (%)
- 12.6.5 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 12.7 South America - Market size and forecast 2024-2029
- Chart on South America - Market size and forecast 2024-2029 ($ billion)
- Data Table on South America - Market size and forecast 2024-2029 ($ billion)
- Chart on South America - Year-over-year growth 2024-2029 (%)
- Data Table on South America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - South America
- Data Table on Regional Comparison - South America
- 12.7.1 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.7.2 Argentina - Market size and forecast 2024-2029
- Chart on Argentina - Market size and forecast 2024-2029 ($ billion)
- Data Table on Argentina - Market size and forecast 2024-2029 ($ billion)
- Chart on Argentina - Year-over-year growth 2024-2029 (%)
- Data Table on Argentina - Year-over-year growth 2024-2029 (%)
- 12.7.3 Colombia - Market size and forecast 2024-2029
- Chart on Colombia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Colombia - Market size and forecast 2024-2029 ($ billion)
- Chart on Colombia - Year-over-year growth 2024-2029 (%)
- Data Table on Colombia - Year-over-year growth 2024-2029 (%)
- 12.8 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Ascendancy of biologics and temperature-sensitive pharmaceuticals
- Globalization of pharmaceutical manufacturing and clinical trials
- Pervasive adoption of digitalization and advanced technologies
- 13.2 Market challenges
- Stringent and fragmented global regulatory landscape
- Maintaining cold chain integrity amidst rising cost pressures
- Heightened supply chain security risks and geopolitical instability
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Hyper-specialization in cryogenic and ultra-low temperature logistics
- Proliferation of AI-powered predictive analytics and digital control towers
- Ascendancy of direct-to-patient and decentralized clinical trial logistics
14 Competitive Landscape
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Bollore Logistics
- Bollore Logistics - Overview
- Bollore Logistics - Product / Service
- Bollore Logistics - Key offerings
- SWOT
- 15.5 CJ CheilJedang Corp.
- CJ CheilJedang Corp. - Overview
- CJ CheilJedang Corp. - Business segments
- CJ CheilJedang Corp. - Key news
- CJ CheilJedang Corp. - Key offerings
- CJ CheilJedang Corp. - Segment focus
- SWOT
- 15.6 CMA CGM Group
- CMA CGM Group - Overview
- CMA CGM Group - Product / Service
- CMA CGM Group - Key news
- CMA CGM Group - Key offerings
- SWOT
- 15.7 DHL International GmbH
- DHL International GmbH - Overview
- DHL International GmbH - Business segments
- DHL International GmbH - Key news
- DHL International GmbH - Key offerings
- DHL International GmbH - Segment focus
- SWOT
- 15.8 DSV AS
- DSV AS - Overview
- DSV AS - Business segments
- DSV AS - Key offerings
- DSV AS - Segment focus
- SWOT
- 15.9 FedEx Corp.
- FedEx Corp. - Overview
- FedEx Corp. - Business segments
- FedEx Corp. - Key news
- FedEx Corp. - Key offerings
- FedEx Corp. - Segment focus
- SWOT
- 15.10 Gemadept Corp.
- Gemadept Corp. - Overview
- Gemadept Corp. - Product / Service
- Gemadept Corp. - Key offerings
- SWOT
- 15.11 GEODIS
- GEODIS - Overview
- GEODIS - Product / Service
- GEODIS - Key offerings
- SWOT
- 15.12 Kuehne Nagel Management AG
- Kuehne Nagel Management AG - Overview
- Kuehne Nagel Management AG - Business segments
- Kuehne Nagel Management AG - Key news
- Kuehne Nagel Management AG - Key offerings
- Kuehne Nagel Management AG - Segment focus
- SWOT
- 15.13 Schenker AG
- Schenker AG - Overview
- Schenker AG - Product / Service
- Schenker AG - Key offerings
- SWOT
- 15.14 SF Express Co. Ltd.
- SF Express Co. Ltd. - Overview
- SF Express Co. Ltd. - Business segments
- SF Express Co. Ltd. - Key offerings
- SF Express Co. Ltd. - Segment focus
- SWOT
- 15.15 Tiong Nam Logistics Holdings Berhad
- Tiong Nam Logistics Holdings Berhad - Overview
- Tiong Nam Logistics Holdings Berhad - Product / Service
- Tiong Nam Logistics Holdings Berhad - Key offerings
- SWOT
- 15.16 United Parcel Service Inc.
- United Parcel Service Inc. - Overview
- United Parcel Service Inc. - Business segments
- United Parcel Service Inc. - Key news
- United Parcel Service Inc. - Key offerings
- United Parcel Service Inc. - Segment focus
- SWOT
- 15.17 YCH Group
- YCH Group - Overview
- YCH Group - Product / Service
- YCH Group - Key offerings
- SWOT
- 15.18 YUSEN LOGISTICS CO. LTD.
- YUSEN LOGISTICS CO. LTD. - Overview
- YUSEN LOGISTICS CO. LTD. - Product / Service
- YUSEN LOGISTICS CO. LTD. - Key offerings
- SWOT
16 Appendix
- 16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
